Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study

Limpaphayom, K; Darmasetiawan, M. S.; Hussain, Rizwan I; Burriss, Susan W; Holinka, Christian F.; Ausmanas, M. K.

doi:10.1080/13697130600722520

Cited by 24 publications

(18 citation statements)

References 31 publications

(39 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Based on the known differences of menopausal symptomatology among different groups of Asian women, as well as differences in culture, lifestyle, attitude toward menopause and multiple other factors [8][9][10]31 , it has been cautioned that conclusions from data of studies in Western postmenopausal women may be of limited value when applied to Asian women 32 . This argument may apply to postmenopausal women of different Asian ethnicities as well.…”

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: The Pan-Asia Menopause (PAM) study

Ausmanas¹,

Tan

Jaisamrarn

et al. 2007

Climacteric

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 98%

“…The PAM study was designed to investigate menopause-associated physical and psychological symptoms [8][9][10] . It documented distinct differences in menopausal symptoms among the nine ethnic groups under investigation 8 .…”

Section: Introductionmentioning

confidence: 99%

Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: The Pan-Asia Menopause (PAM) study

Ausmanas¹,

Tan

Jaisamrarn

et al. 2007

Climacteric

Self Cite

View full text Add to dashboard Cite

show abstract

“…MENQOL was developed in 1996 and it consists of four domains: vasomotor, psychological, physical and sexual. MENQOL has been applied in Europe [3], China and in some other developing countries [4,5].…”

Section: Discussionmentioning

confidence: 99%

The Quality of Life During and After Menopause Among Rural Women

Arounassalame¹

2013

JCDR

View full text Add to dashboard Cite

Introduction:The overall health and well-being of middle-aged women has become a major public health concern around the world. More than 80% of the women experience physical or psychological symptoms in the years when they approach menopause, with various distresses and disturbances in their lives, leading to a decrease in the quality of life. The aim of our study was to assess the quality of life and the impact of hormonal changes in perimenopausal and postmenopausal women and to correlate the prevalence of the symptoms with their duration since menopause. Material and Methods:A cross-sectional study was done at Sri Manakula Vinayagar Medical College and Hospital, Puducherry, from January 2012 to April 2012. Five hundred women who were in the age group of 40-65 years, who came from rural areas to our hospital, were included in the study. The women who were receiving hormonal treatment and those who refused to participate in the study were excluded. The data such as the socio-demographic information and the menstruation status, which were based on the reported length of time since the last menstrual period and the experience of the symptoms, as were tested in the Menopause Specific Quality of Life (MENQOL) questionnaire, were collected from each patient. The women who were included in the study were divided into three groups as the menopause transition, early postmenopausal and the late postmenopausal groups. All the data which were gathered were analyzed by using SAS 9.2. The Chi square test and the relative risk and the confidence interval calculations were applied to compare the frequencies of the symptoms among the women with different menopausal statuses. A p-value of less than 0.05 was considered to be statistically significant. Results:Mean menopausal age in the study group was 45 years. The most common symptom within study subjects were low back ache (79%) and muscle-joint pain (77.2%). The least frequent symptoms were increase in facial hair (15%) and feeling of dryness during intimacy (10.8%). Scores of vasomotor domain were significantly more in menopause transition group. Scores of physical domain were significantly more in late postmenopausal group. Conclusion:The menopause related symptoms had a negative effect on the quality of life of the perimenopausal and the postmenopausal women. Such regional studies can help in creating awareness and in educating women on the early identification of the common menopausal symptoms.

show abstract

“…The population of Asian women described in the present report also exhibited comparable therapeutic responses to three different doses of CE/ MPA, including the low dose of 0.3/1.5 mg/day 5 . Beneficial responses that were comparable at the three dose levels included relief of vasomotor symptoms and vaginal atrophy and alleviation of a number of other menopause-related symptoms 6 , as well as improvement in quality of life 7 .…”

Section: Introductionmentioning

confidence: 98%

Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study

Ausmanas¹,

Holinka

Ling

et al. 2007

Climacteric

Self Cite

View full text Add to dashboard Cite

show abstract

Differential prevalence of quality-of-life categories (domains) in Asian women and changes after therapy with three doses of conjugated estrogens/medroxyprogesterone acetate: the Pan-Asia Menopause (PAM) study

Cited by 24 publications

References 31 publications

Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: The Pan-Asia Menopause (PAM) study

Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: The Pan-Asia Menopause (PAM) study

The Quality of Life During and After Menopause Among Rural Women

Effect of three doses of conjugated estrogens/medroxyprogesterone acetate on biomarkers of bone turnover and cartilage degradation in postmenopausal women: The Pan-Asia Menopause (PAM) study

Contact Info

Product

Resources

About